Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "informed horizons" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about informed horizons for you to read. Along with our medical data and news we also list informed horizons Clinical Trials, which are updated daily. BioPortfolio also has a large database of informed horizons Companies for you to search.
New drug combinations and pathways continue to be mined in an effort to expand treatment horizons for control of a rare lymphoma and extend quality of life for patients over many years to come. Medscape Medical News
OTTAWA, ONTARIO - March 20, 2018 (Investorideas.com Newswire) Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has been added to the Horizons Marijuana Life Sciences Index (HMMJ) managed by Horizons ETFs Management (Canada) Inc.
Live video perspectives from ophthalmology meetings give viewers the opportunity to hear a condensed version of speakers’ presentations.So far in 2018, Healio.com/OSN has attended Hawaiian Eye 2018 and Retina 2018, the Glaucoma 360: New Horizons Forum and the European Society of Cataract and Refractive Surgeons winter meeting to interview physicians regarding their presentations.Here are the top...
The NEO Exchange (“NEO”) is pleased to announce that Horizons ETFs Management (Canada) Inc. (“Horizons ETFs”) launched the Horizons Emerging Marijuana Growers Index ETF on NEO today. With the launch of this new ETF, represented by the ticker HMJR, Horizons ETFs
Bright Horizons Family Solutions® is a leading provider of high-quality child care, early education and other services designed to help employers and families better address the challenges of work and family life. The Company provides full service center-based child care, back-up dependent care and educational advisory services to more than 1,100 clients ...
Analysis of the 2018 ASCO abstracts shows beyond PD-1, researchers are broadening their horizons to try a spectrum of new approaches in cancer.
Providing information to enable informed choices about healthcare sounds immediately appealing to most of us. But Minna Johansson, GP trainee and PhD student at the University of Gothenburg, argues that preventive medicine and expanding disease definitions have changed the ethical premises of informed choice and our good intentions may...
Houston, Texas – Advanced pancreatic cancer is a very tough disease to treat, so it is not surprising that by…
Funding round co-led by new investor Horizons Ventures and existing investor Aviva Read more...
bmj;362/jul04_3/k2467/FAF1faDuncan SmithBiographyIf Helen Bevan were a character in the BBC comedy W1A she would be “Director of Better.” In the real world she is chief transformation officer of NHS...
(Fundação de Amparo à Pesquisa do Estado de São Paulo) Brazilian researchers combine chip technology with laser calibration to enhance an infrared spectrometer which could be integrated to drones, smartphones and other portable devices.
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, co-chairs of Glaucoma 360, discuss innovations presented at the meeting and the 3 days of events that comprise the conference.
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Kfir Azoulay, vice president and head of corporate strategy at Heidelberg Engineering, discusses the Spectralis imaging platform.
Carmot Therapeutics Inc. raised $15mm through its Series B financing led by first-time backer Horizons Ventures and returning...
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Ram Palanki, PharmD, senior vice president of the Americas commercial for Santen, discusses the company’s pipeline in glaucoma therapy and clinical trials taking place globally.
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Jeffrey L. Goldberg, MD, PhD, professor and chair of ophthalmology at the Byers Eye Institute at Stanford University, discusses new glaucoma therapies that show promise to not only lower IOP but also provide neuroprotection.
New findings could change how iron metabolism in the human body is understood, and open new horizons for research and therapeutics for inflammatory diseases and neurodegenerative diseases, such as Alzheimer’s and Parkinson's disease.
OTTAWA, ONTARIO -- (Marketwired) -- 03/20/18 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX VENTURE: TBP)(OTCQB: TBPMF), a global leader in cannabinoid-based drug development and discover...
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the build-out the company is performing to ramp up for the commercial launch of Rhopressa for the treatment of glaucoma and gives an update on clinical trials of Roclatan.
In 2015, University of California San Diego biologists Ethan Bier and Valentino Gantz developed a breakthrough technology known as "active genetics," which results in parents transmitting a genetic trait to most of their offspring (instead of 50 percent receiving the trait under standard inheritance).
SAN FRANCISCO ― Ike K. Ahmed, MD, kicked off the Glaucoma 360: New Horizons Forum with the Drs. Henry and Frederick Sutro Memorial Lecture, in which he talked about interventional glaucoma treatment ushering in a new and disruptive approach to glaucoma treatment.
First-of-its-kind app allows parents to instantly reserve back-up child care Bright Horizons Family Solutions® Inc. (NYSE: BFAM) has launched the first mobile solution for working parents to make instant reservations for child care when their regular care falls through. Key features of the application include the ability to book and confirm bot...
Bonterra continues to advance the development of the Gladiator Gold Deposit through definition drilling across all mineralized horizons. Follow up on previous step-out drilling has Read more...
SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Felipe Medeiros, MD, PhD, professor of ophthalmology at Duke University, discusses the development of the nGoggle, a device that merges virtual reality goggle technology with electroencephalogram technology to help assess visual function.